Skip to main content
. 2023 Jun 6;28(12):e1160–e1169. doi: 10.1093/oncolo/oyad159

Figure 5.

Figure 5.

Recurrence-free survival (RFS) and overall survival (OS) Kaplan-Meier curves. RFS for HER2-zero vs. HER2-low tumors in the (A) entire HER2-negative population, (B) HR-positive, and (C) HR-negative subgroups, and OS for HER2-zero vs. HER2-low tumors in the (D) entire cohort, (E) HR-positive, and (F) HR-negative population.